drugset / Trial / NCT04415268
Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis
Withdrawn
Universidad Europea de Madrid
NaSingle-groupOpen-labelTreatment
Summary
This study aims to assess the effects of programmed exercise combined with CFTR protein modulator drugs in the cardiorespiratory fitness, strength, functional capacity and agility in a group of young patients with Cystic Fibrosis.
Timeline
- Start
- 2020-06-09
- Primary completion
- 2021-01-29
- Completion
- 2021-05-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivacaftor | Other / unclassified | 150 mg | — |
| Subject | Ivacaftor | Other / unclassified | 250 mg | — |
| Subject | Lumacaftor | Small molecule | 200 mg | — |
| Subject | tezacaftor | Other / unclassified | 100 mg | — |